JETT FOUNDATION " HERE IS WHY DRUG WILL BE APPROVED. LINK
jETT FOUNDATION LINK
About Accelerated Approval:
Under the accelerated approval process, researchers can use a surrogate endpoint to show efficacy. Approval of a drug based on such endpoints is given on the condition that post marketing clinical trials verify the anticipated clinical benefit. This can allow researchers to skip ahead to phase 4 confirmatory trials, expediting the timeline for approval.